Adrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in Man
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index; none of the 16 sources its claims cite is checked for support yet.
Abstract
THE PRESENT STUDIES WERE UNDERTAKEN TO ASSESS THE ADRENERGIC MECHANISMS BY WHICH EPINEPHRINE STIMULATES GLUCOSE PRODUCTION AND SUPPRESSES GLUCOSE CLEARANCE IN MAN: epinephrine (50 ng/kg per min) was infused for 180 min alone and during either alpha (phentolamine) or beta (propranolol)-adrenergic blockade in normal subjects under conditions in which plasma insulin, glucagon, and glucose were maintained at comparable levels by infusion of somatostatin (100 mug/h), insulin (0.2 mU/kg per min), and variable amounts of glucose. In additional experiments, to control for the effects of the hyperglycemia caused by epinephrine, variable amounts of glucose without epinephrine were infused along with somatostatin and insulin to produce hyperglycemia comparable with that observed during infusion of epinephrine. This glucose infusion suppressed glucose production from basal rates of 1.8+/-0.1 to 0.0+/-0.1 mg/kg per min (P < 0.01), but did not alter glucose clearance. During infusion of epinephrine, glucose production increased transiently from a basal rate of 1.8+/-0.1 to a maximum of 3.0+/-0.2 mg/kg per min (P < 0.01) at min 30, and returned to near basal rates at min 180 (1.9+/-0.1 mg/kg per min). Glucose clearance decreased from a basal rate of 2.0+/-0.1 to 1.5+/-0.2 ml/kg per min at the end of the epinephrine infusion (P < 0.01). Infusion of phentolamine did not alter these effects of epinephrine on glucose production and clearance. In contrast, infusion of propranolol completely prevented the suppression of glucose clearance by epinephrine, and inhibited the stimulation of glucose production by epinephrine by 80+/-6% (P < 0.001). These results indicate that, under conditions in which plasma glucose, insulin, and glucagon are maintained constant, epinephrine stimulates glucose production and inhibits glucose clearance in man predominantly by beta adrenergic mechanisms.
Overview
CoChat Summary
TL;DR
In normal human subjects with plasma insulin, glucagon, and glucose clamped, epinephrine increased endogenous glucose production transiently and decreased glucose clearance. These effects were predominantly mediated by beta-adrenergic mechanisms, since propranolol largely blocked them while phentolamine did not.
Key findings
- Epinephrine infusion increased endogenous glucose production from a basal rate of 1.8±0.1 to a maximum of 3.0±0.2 mg/kg per min at min 30, then returned to near basal values (1.9±0.1 mg/kg per min) at min 180; glucose clearance decreased from 2.0±0.1 to 1.5±0.1 ml/kg per min from 90 through 180 min (P < 0.01 vs. basal).
- Glucose infusion alone, producing comparable hyperglycemia without epinephrine, suppressed endogenous glucose production from 1.8±0.1 to 0.0±0.1 mg/kg per min (P < 0.01) but did not alter glucose clearance.
- Propranolol completely prevented the suppression of glucose clearance by epinephrine and inhibited epinephrine-stimulated glucose production by 80±6% (P < 0.001).
- Phentolamine did not significantly alter epinephrine’s effects on glucose production or clearance; the authors conclude that epinephrine stimulates glucose production and suppresses glucose clearance predominantly by beta-adrenergic mechanisms.
Methods
- Four protocols were performed in five healthy female adult volunteers aged 19–21 yr; all subjects completed protocols A, B, and C, and four completed protocol D.
- Somatostatin (100 μg/h), insulin (0.2 mU/kg per min), and variable glucose were infused to maintain comparable plasma insulin, glucagon, and glucose levels; epinephrine (50 ng/kg per min) was infused alone or with propranolol or phentolamine.
- Glucose kinetics were measured with [3-3H]glucose using Steele et al. equations as modified by DeBodo et al.; endogenous glucose production was calculated by subtracting exogenous glucose infusion, and glucose clearance was glucose disappearance divided by plasma glucose. Statistical analysis used two-tailed paired t tests on data from the stable clamp interval 90–180 min.
Limitations
- The authors state that the studies do not identify the tissues whose glucose clearance was affected by epinephrine or whether the effects were due to direct action on those tissues.
- The authors state that incomplete reversal of epinephrine-stimulated glucose production by propranolol could indicate a 20% alpha-adrenergic contribution or incomplete beta-adrenergic blockade; they favor incomplete beta blockade, partly because alpha blockade had no measurable effect.
- The authors note that plasma epinephrine rose about threefold higher during epinephrine plus propranolol than during epinephrine alone, suggesting beta blockade reduces epinephrine clearance; they state this may explain the failure of beta blockade to completely block glucose production.
- Evident from the text: the sample was very small (five healthy young women, four in one protocol), all subjects were female and within 10% of ideal body weight, and the findings may not generalize to other populations or disease states.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 0 Not valid · 11 Not checked · 35 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, plasma epinephrine concentrations, when epinephrine was infused along with propranolol (2,142±137 pg/ml), were approximately threefold greater than those observed when epinephrine was infused without propranolol (P < 0.001).”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This glucose infusion suppressed glucose production from basal rates of 1.8±0.1 to 0.0±0.1 mg/kg per min (P < 0.01)”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Infusion of epinephrine at a rate of 50 ng/kg per min increased plasma epinephrine from a basal concentration of 26±4 pg/ml to levels averaging 882±60 pg/ml, from 90 through 180 min.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“but did not alter glucose clearance.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Endogenous glucose production decreased from a basal rate of 1.8±0.1 to 0.4±0.1 mg/kg per min during the interval from 90 through 180 min (P < 0.001); this rate was significantly less than that observed over the same interval during infusion of epinephrine without propranolol (P < 0.001) and represented a 81±6% suppression of epinephrine-stimulated glucose production.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims
Create a free account to see all 46 claims and every source verdict.
- It may state two separate claims as one. 7
- Probably not a substantial claim. 15
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Adrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in Man · p. 1
“returned to near basal rates at min 180 (1.9±0.1 mg/kg per min).”
§ RESULTS · p. 4
“then returned to approximately basal values (1.9±0.3 mg/kg per min) at min 180.”
Citations
Cites
Feinleib, M., & Zar, J. H. (1975) · Journal of the American Statistical Association · doi:10.2307/2285423 · Cited by 12,680
Zar, J. H. (1996) · Cited by 7,837
Coated Charcoal Immunoassay of Insulin
HERBERT, V., LAU, K.-S., GOTTLIEB, C. W., & BLEICHER, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,968
Measurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Randle, P., Newsholme, E., & Garland, P. (1964) · Biochemical Journal · doi:10.1042/bj0930652 · Cited by 736
Effects of arterial versus venous sampling on analysis of glucose kinetics in man
McGuire, E. A., Helderman, J. H., Tobin, J. D., Andres, R., & Berman, M. (1976) · Journal of Applied Physiology · doi:10.1152/jappl.1976.41.4.565 · Cited by 704
Epinephrine-induced insulin resistance in man
Deibert, D. C., & Defronzo, R. A. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109718 · Cited by 557
ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE.
DeBodo, R. C., Steele, R., ALTSZULER, N., Dunn, A., & Bishop, J. (1963) · PubMed · Cited by 532
EFFECT OF EPINEPHRINE ON RAT DIAPHRAGM
Walaas, O., & Walaas, E. (1950) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56223-2 · Cited by 410
A Receptor Mechanism for the Inhibition Of Insulin Release by Epinephrine in Man*
Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105514 · Cited by 398
Cited by
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Assessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
RIZZA, R. A., MANDARINO, L. J., & GERICH, J. E. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-1-131 · Cited by 696
Self-citationDose-response characteristics for effects of insulin on production and utilization of glucose in man
Rizza, R. A., Mandarino, L. J., & Gerich, J. E. (1981) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1981.240.6.e630 · Cited by 703
Self-citationPhysiology and Pathophysiology of the Human Sympathoadrenal Neuroendocrine System
Bleich, H. L., Moore, M. J., & Cryer, P. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198008213030806 · Cited by 652
Self-citationKolterman, O. G., Gray, R. S., Griffin, J., Burstein, P., Insel, J., Scarlett, J. A., & Olefsky, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110350 · Cited by 629
Insulin Resistance in Chronic Heart Failure: Relation to Severity and Etiology of Heart Failure
Swan, J. W., Anker, S. D., Walton, C., Godsland, I. F., Clark, A. L., Leyva, F., Stevenson, J. C., & Coats, A. J. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00185-x · Cited by 533
“However, some studies (14,15) have implicated increased catecholamine levels as a cause of insulin resistance (and hyperinsulinemia) in patients without heart disease, indicating that a disturbance of the normal feedback mechanism may occur in insulin-resistant states.”
BackgroundFrequency, Risk Factors, and Outcome of Hyperlactatemia After Cardiac Surgery
Maillet, J.-M., Le Besnerais, P., Cantoni, M., Nataf, P., Ruffenach, A., Lessana, A., & Brodaty, D. (2003) · Chest · doi:10.1378/chest.123.5.1361 · Cited by 401
White, N. H., Skor, D. A., Cryer, P. E., Levandoski, L. A., Bier, D. M., & Santiago, J. V. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303033080903 · Cited by 391
Self-citationIntense Exercise Has Unique Effects on Both Insulin Release and Its Roles in Glucoregulation
Marliss, E. B., & Vranic, M. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s271 · Cited by 390
“Most human studies have suggested a predominance of -receptor stimulation of GP (30,39).”
BackgroundEarly postexercise muscle glycogen recovery is enhanced with a carbohydrate-protein supplement
Ivy, J. L., Goforth, H. W., Damon, B. M., McCauley, T. R., Parsons, E. C., & Price, T. B. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00394.2002 · Cited by 352
“In the present study, the increased glycogen storage during the CHO-Pro treatment could not be attributed to a greater plasma insulin response, nor could it be attributed to differences in plasma catecholamines or circulating FFA levels, both of which can antagonize the action of insulin (4, 16, 20, 25).”
BackgroundGlucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus
Epstein, F. H., Cryer, P. E., & Gerich, J. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507253130405 · Cited by 273
Self-citationPagano, G., Cavallo-Perin, P., Cassader, M., Bruno, A., Ozzello, A., Masciola, P., Dall'omo, A. M., & Imbimbo, B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111141 · Cited by 259
Lembo, G., Napoli, R., Capaldo, B., Rendina, V, Iaccarino, G., Volpe, M., Trimarco, B., & Saccà, L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115842 · Cited by 252
Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action
Hansen, I., Tsalikian, E., Beaufrere, B., Gerich, J., Haymond, M., & Rizza, R. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.3.e269 · Cited by 215
Self-citationCampbell, P. J., Bolli, G. B., Cryer, P. E., & Gerich, J. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506063122302 · Cited by 218
Self-citationGlucose counterregulation: prevention and correction of hypoglycemia in humans
Cryer, P. E. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.2.e149 · Cited by 198
Self-citationMuscle glycogenolysis during exercise: dual control by epinephrine and contractions
Richter, E. A., Ruderman, N. B., Gavras, H., Belur, E. R., & Galbo, H. (1982) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1982.242.1.e25 · Cited by 194
Inhibitory Effect of Epinephrine on Insulin-stimulated Glucose Uptake by Rat Skeletal Muscle
Chiasson, J.-L., Shikama, H., Chu, D. T. W., & Exton, J. H. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110306 · Cited by 178
Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure
Paolisso, G., De Riu, S., Marrazzo, G., Verza, M., Varricchio, M., & D'Onofrio, F. (1991) · Metabolism · doi:10.1016/0026-0495(91)90075-8 · Cited by 174
Watt, M. J., Howlett, K. F., Febbraio, M. A., Spriet, L. L., & Hargreaves, M. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.t01-1-00269.x · Cited by 173
“It has been shown previously that the administration of adrenaline decreases glucose MCR in humans at rest (Rizza et al. 1980), but during exercise the data are less conclusive.”
BackgroundHypoglycaemia in Elderly Patients with Diabetes Mellitus: Causes and Strategies for Prevention
Chelliah, A., & Burge, M. R. (2004) · Drugs & Aging · doi:10.2165/00002512-200421080-00003 · Cited by 165
Taylor, R., & Agius, L. (1988) · Biochemical Journal · doi:10.1042/bj2500625 · Cited by 164
Allon, M., & Shanklin, N. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90460-6 · Cited by 159
APPLE, J. K., Dikeman, M. E., Minton, J. E., McMurphy, R. M., Fedde, M. R., Leith, D. E., & Unruh, J. A. (1995) · Journal of Animal Science · doi:10.2527/1995.7382295x · Cited by 210
Type B lactic acidosis following cardiopulmonary bypass
Raper, R. F., Cameron, G., Walker, D., & Bowey, C. J. (1997) · Critical Care Medicine · doi:10.1097/00003246-199701000-00011 · Cited by 153
Insulin regulation of renal glucose metabolism in conscious dogs.
Cersosimo, E., Judd, R. L., & Miles, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117270 · Cited by 133
Acute noradrenergic activation induces insulin resistance in human skeletal muscle
Lembo, G., Capaldo, B., Rendina, V., Iaccarino, G., Napoli, R., Guida, R., Trimarco, B., & Sacca, L. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.2.e242 · Cited by 136
James, D. E., Burleigh, K. M., & Kraegen, E. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84571-4 · Cited by 136
Martínez‐Sánchez, N., Sweeney, O., Sidarta-Oliveira, D., Caron, A., Stanley, S. A., & Domingos, A. I. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.017 · Cited by 134
Hyperkalemia in end-stage renal disease: mechanisms and management.
Allon, M. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v641134 · Cited by 131
Insulin secretion and action in patients with pancreatic cancer
Cersosimo, E., Pisters, P. W. T., Pesola, G., McDermott, K., Bajorunas, D., & Brennan, M. F. (1991) · Cancer · doi:10.1002/1097-0142(19910115)67:2<486::aid-cncr2820670228>3.0.co;2-1 · Cited by 121
Studer, R., & Borle, A. B. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34286-8 · Cited by 126
Exercise and Glycemic Control in Diabetes: Benefits, Challenges, and Adjustments to Pharmacotherapy
Gulve, E. A. (2008) · Physical Therapy · doi:10.2522/ptj.20080114 · Cited by 120
Cryer, P. E., Rizza, R. A., Haymond, M. W., & Gerich, J. E. (1980) · Metabolism · doi:10.1016/0026-0495(80)90019-0 · Cited by 115
Self-citationPopp, D. A., Shah, S. D., & Cryer, P. E. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110455 · Cited by 112
Self-citationBarsheshet, A., Garty, M., Grossman, E., Sandach, A., Lewis, B. S., Gottlieb, S., Shotan, A., Behar, S., Caspi, A., Schwartz, R., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1613 · Cited by 109
“Activation of the sympathetic system not only increases insulin resistance but also decreases the release of insulin from the pancreatic beta cells and increases hepatic glucose production by stimulating both gluconeogenesis and glycogenolysis.(18,19) However, hyperglycemia may contribute to exacerbation of HF by seve…”
BackgroundBolli, G. B., Tsalikian, E., Haymond, M. W., Cryer, P. E., & Gerich, J. E. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111359 · Cited by 108
Self-citationCeli, F. S., Brychta, R. J., Linderman, J. D., Butler, P. W., Alberobello, A. T., Smith, S., Courville, A. B., Lai, E. W., Costello, R., Skarulis, M. C., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0627 · Cited by 100
Nielsen, O. H., Henriksen, J. E., Holst, J. J., & Beck-Nielsen, H. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90204-8 · Cited by 106
Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog
McGuinness, O. P., Fugiwara, T., Murrell, S., Bracy, D., Neal, D., O'Connor, D., & Cherrington, A. D. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.2.e314 · Cited by 102
Davis, S. N., Mann, S., Galassetti, P., Neill, R. A., Tate, D., Ertl, A. C., & Costa, F. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1897 · Cited by 100
Purdon, C. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.3.566 · Cited by 105
Bell, P. M., Firth, R. G., & Rizza, R. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112739 · Cited by 97
Self-citationInsulin regulation of renal glucose metabolism in humans
Cersosimo, E., Garlick, P., & Ferretti, J. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.1.e78 · Cited by 97
“On the basis of these findings with a combination of arteriovenous balance and tracer dilution across the kidney, it appears that a more complicated model of glucoregulation, which takes into account possible different effects on the kidney and liver of the large number of hormones (17, 35, 37) and substrates (2, 18,…”
BackgroundRole of glycogen concentration and epinephrine on glucose uptake in rat epitrochlearis muscle.
Jensen, J., Aslesen, R., Ivy, J. L., & Brors, O. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.4.e649 · Cited by 95
Treatment and prevention of hyperkalemia in end-stage renal disease
Allon, M. (1993) · Kidney International · doi:10.1038/ki.1993.170 · Cited by 91
Laakso, M., Uusitupa, M. I. J., Takala, J., Majander, H., Reijonen, T., & Penttilä, I. (1988) · Metabolism · doi:10.1016/0026-0495(88)90074-1 · Cited by 91
Hormonal effects of norepinephrine on acute glucose disposal in humans: A minimal model analysis
Marangou, A. G., Alford, F. P., Ward, G., Liskaser, F., Aitken, P. M., Weber, K. M., Boston, R. C., & Best, J. D. (1988) · Metabolism · doi:10.1016/0026-0495(88)90124-2 · Cited by 83
Regulation of glucose metabolism by sympathochromaffin catecholamines
Clutter, W. E., Rizza, R. A., Gerich, J. E., & Cryer, P. E. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040104 · Cited by 83
Self-citationBerk, M. A., Clutter, W. E., Skor, D., Shah, S. D., Gingerich, R. P., Parvin, C. A., & Cryer, P. E. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111898 · Cited by 82
Self-citationRelationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes
Frontoni, S., Bracaglia, D., & Gigli, F. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.06.010 · Cited by 90
Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans.
Alzaid, A. A., Dinneen, S. F., Turk, D. J., Caumo, A., Cobelli, C., & Rizza, R. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117599 · Cited by 80
Self-citationEssential hypertension and insulin resistance in non‐insulin‐dependent diabetes
Laakso, M., Sarlund, H., & Mykkänen, L. (1989) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1989.tb00269.x · Cited by 87
Role of hepatic autoregulation in defense against hypoglycemia in humans.
Bolli, G., De Feo, P., Perriello, G., De Cosmo, S., Ventura, M., Campbell, P., Brunetti, P., & Gerich, J. E. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111869 · Cited by 79
“Cortisol (41, 42), growth hormone (43, 44), epinephrine (42, 45, 46), and norepinephrine (46), when administered in amounts producing circulating levels observed during hypoglycemia, have all been shown to impair glucose utilization.”
BackgroundSelf-citationAdrenergic mechanisms of catecholamine action on glucose homeostasis in man
Rizza, R. A., Cryer, P. E., Haymond, M. W., & Gerich, J. E. (1980) · Metabolism · doi:10.1016/0026-0495(80)90025-6 · Cited by 86
Self-citationLager, I., Attvall, S., Eriksson, B. M., Schenk, H., & Smith, U. (1986) · Diabetologia · doi:10.1007/bf00506530 · Cited by 90
“This effect, then, appears to be mediated solely by/q-receptor stimulation, which is in agreement with other recent suggestions [9, 32].”
ResultPsychosocial components of the stress process in bulimia
Cattanach, L., & Rodin, J. (1988) · International Journal of Eating Disorders · doi:10.1002/1098-108x(198801)7:1<75::aid-eat2260070108>3.0.co;2-a · Cited by 78
Mechanisms of insulin resistance in man
Rizza, R. A., Mandarino, L. J., & Gerich, J. E. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90423-x · Cited by 88
Self-citationFanelli, C. G., De Feo, P., Porcellati, F., Perriello, G., Torlone, E., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115809 · Cited by 77
GALASSETTI, P., & DAVIS, S. N. (2000) · Clinical Science · doi:10.1042/cs0990351 · Cited by 72
Glucose kinetics during prolonged exercise in euglycaemic and hyperglycaemic subjects
Hawley, J. A., Bosch, A. N., Weltan, S. M., Dennis, S. C., & Noakes, T. D. (1994) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00388300 · Cited by 75
“Several possible explanations have been proposed for this paradox including recycling of the tracer [26, 27, 33], incorporation of the tracer into glycogen followed by release of labelled glucose during glycogenolysis [3], methodological error in the processing and or measurement of the specific activity of tritiated…”
MethodEffect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs
Cherrington, A. D., Fuchs, H., Stevenson, R. W., Williams, P. E., Alberti, K. G., & Steiner, K. E. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.2.e137 · Cited by 75
Insulin-counteracting hormones: Their impact on glucose metabolism
Bratusch-Marrain, P. R. (1983) · Diabetologia · doi:10.1007/bf00297384 · Cited by 82
Role of β-adrenergic receptors in regulation of hepatic fat accumulation during aging
Ghosh, P., Shu, Z.-J., Zhu, B., Lu, Z., Ikeno, Y., Barnes, J. L., Yeh, C., Zhang, B.-X., Katz, M. S., & Kamat, A. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0406 · Cited by 74
Underestimation of hepatic glucose production by radioactive and stable tracers
Argoud, G. M., Schade, D. S., & Eaton, R. P. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.5.e606 · Cited by 72
Adrenergic Receptors in Human Liver Plasma Membranes: Predominance of β2- and α1-Receptor Subtypes*
Kawai, Y., POWELL, A., & Arinze, I. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-827 · Cited by 66
Dose-related effects of epinephrine on glucose production in conscious dogs
Stevenson, R. W., Steiner, K. E., Connolly, C. C., Fuchs, H., Alberti, K. G., Williams, P. E., & Cherrington, A. D. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.3.e363 · Cited by 69
Overview of counterregulation and its abnormalities in diabetes mellitus and other conditions
Gerich, J. E., & Campbell, P. J. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040202 · Cited by 74
Self-citationBruce, D. G., Chisholm, D. J., Storlien, L. H., Kraegen, E. W., & Smythe, G. A. (1992) · Diabetologia · doi:10.1007/bf00399929 · Cited by 70
Catecholamine-induced insulin resistance of glucose transport in isolated rat adipocytes
Kirsch, D., Baumgarten, M., Deufel, T., Rinninger, F., KEMMLER, W. K., & Häring, H.-U. (1983) · Biochemical Journal · doi:10.1042/bj2160737 · Cited by 64
Effects of epinephrine on glucose metabolism in contracting rat skeletal muscles
Aslesen, R., & Jensen, J. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.3.e448 · Cited by 63
“During insulin stimulation, it is well documented that epinephrine decreases glucose clearance in vivo (32) and, in agreement with this, epinephrine inhibits insulin-stimulated glucose uptake in skeletal muscles (5, 12, 14).”
BackgroundHoelzer, D. R., Dalsky, G. P., Clutter, W. E., Shah, S. D., Holloszy, J. O., & Cryer, P. E. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112279 · Cited by 62
Self-citationRetractedAdrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.
Simonson, D. C., Koivisto, V, Sherwin, R. S., Ferrannini, E., Hendler, R., Juhlin-Dannfelt, A., & DeFronzo, R. A. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111371 · Cited by 63
Calcium attenuates epinephrine's beta-adrenergic effects in postoperative heart surgery patients.
Zaloga, G. P., Strickland, R. A., Butterworth, J. F. I., MARK, L. J., Mills, S. A., & Lake, C. R. (1990) · Circulation · doi:10.1161/01.cir.81.1.196 · Cited by 60
Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia
Allon, M., Takeshian, A., & Shanklin, N. (1993) · Kidney International · doi:10.1038/ki.1993.34 · Cited by 60
Mechanisms of Epinephrine-induced Glucose Intolerance in Normal Humans
Saccà, L., Vigorito, C., Cicala, M., Ungaro, B., & Sherwin, R. S. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110451 · Cited by 59
Glucoregulation during and after intense exercise: effects of beta-blockade.
Sigal, R. J., Purdon, C., Bilinski, D., Vranic, M., Halter, J. B., & Marliss, E. B. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.7906280 · Cited by 59
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Ayala, J. E., Bracy, D. P., Malabanan, C., James, F. D., Ansari, T., Fueger, P. T., McGuinness, O. P., & Wasserman, D. H. (2011) · Journal of Visualized Experiments · doi:10.3791/3188-v · Cited by 56
Hypoglycemia in diabetes: common, often unrecognized.
Gabriely, I., & Shamoon, H. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.4.335 · Cited by 58
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.2.e199 · Cited by 57
Hypothermia is critical for survival during prolonged insulin-induced hypoglycemia in rats
Buchanan, T. A., Cane, P., Eng, C. C., Sipos, G. F., & Lee, C. T. (1991) · Metabolism · doi:10.1016/0026-0495(91)90118-g · Cited by 55
Kreisman, S. H., Halter, J. B., Vranic, M., & Marliss, E. B. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1347 · Cited by 56
Hother‐Nielsen, O., Møngel, A., Møller, J., Rasmussen, O., Schmitz, O., & Beck‐Nielsen, H. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01903.x · Cited by 56
Effect of albuterol treatment on subsequent dialytic potassium removal
Allon, M., & Shanklin, N. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90597-9 · Cited by 55
Effects of epinephrine infusion on leucine and alanine kinetics in humans
Miles, J. M., Nissen, S., Gerich, J. E., & Haymond, M. W. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.2.e166 · Cited by 65
Self-citationGlucose counterregulation during prolonged hypoglycemia in normal humans
Bolli, G. B., Gottesman, I. S., Cryer, P. E., & Gerich, J. E. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.2.e206 · Cited by 52
Self-citationChu, C. A., Sindelar, D. K., Igawa, K., Sherck, S. M., Neal, D. W., Emshwiller, M., & Cherrington, A. D. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.2.e463 · Cited by 53
Alterations of insulin and glucose metabolism during cardiopulmonary bypass under normothermia
Kuntschen, F., Galletti, P. M., Hahn, C., Arnulf, J. J., Isetta, C., & Dor, V. (1985) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)38854-3 · Cited by 56
McLeod, A. A., Brown, J. E., Kuhn, C. M., Kitchell, B. B., Sedor, F. A., Williams, R. S., & Shand, D. G. (1983) · Circulation · doi:10.1161/01.cir.67.5.1076 · Cited by 51
Scheen, A. J., & Ernest, P. (2002) · PubMed · Cited by 58
In Vivo Regulation of Non-Insulin-Mediated and Insulin-Mediated Glucose Uptake by Epinephrine*
BARON, A. D., WALLACE, P., & OLEFSKY, J. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-889 · Cited by 50
β-Adrenergic blockade augments glucose utilization in horses during graded exercise
Geor, R. J., Hinchcliff, K. W., & Sams, R. A. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.3.1086 · Cited by 56
“That this Epi-induced reduction in glucose Rd can be mitigated by propranolol infusion implicates b-adrenergic mechanisms in the inhibition of glucose uptake (38).”
BackgroundKomada, H., Hirota, Y., So, A., Nakamura, T., Okuno, Y., Fukuoka, H., Iguchi, G., Takahashi, Y., Sakaguchi, K., & Ogawa, W. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00357 · Cited by 52
“Catecholamines also antagonize insulin action in target organs (12, 13) and might, thereby, trigger insulin resistance.”
Bjorkman, O., Miles, P., Wasserman, D., Lickley, L., & Vranic, M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113517 · Cited by 48
Epinephrine infusion during moderate intensity exercise increases glucose production and uptake
Kreisman, S. H., Mew, N. A., Arsenault, M., Nessim, S. J., Halter, J. B., Vranic, M., & Marliss, E. B. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.5.e949 · Cited by 48
“Although some (5, 30) produced Epi levels comparable to those of IE, the 1.”
ResultZhang, Z., & Ni, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120466 · Cited by 47
“It can be further sub-divided depending on whether it is caused by underlying disease (B1), drugs and toxins (B2) or inborn errors of metabolism (B3) [13].”
BackgroundSleep-related intermittent hypoxemia and glucose intolerance: a community-based study
Tanno, S., Tanigawa, T., Saito, I., Nishida, W., Maruyama, K., Eguchi, E., Sakurai, S., Osawa, H., & Punjabi, N. M. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.05.027 · Cited by 46
“Increase in circulating catecholamines impairs insulin sensitivity [25], decreases insulin secretion [26], and reduces insulin-mediated glucose uptake [27].”
BackgroundTenenbaum, A., & Fisman, E. Z. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404050-00001 · Cited by 50
Berlin, I., Grimaldi, A., Landault, C., Cesselin, F., & Puech, A. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962339 · Cited by 34
Metadata
- Authors
- Rizza, R. A., Cryer, P. E., Haymond, M. W., & Gerich, J. E.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Haymond, M. W.
- Venue
- Journal of Clinical Investigation
- Published
- 1980-03-01
- Volume
- 65
- Issue
- 3
- Pages
- 682-689
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC371410
- OpenAlex
- W2103557599
- Cited by
- 340
- References
- 33
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 6 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 6 · 2014: 9 · 2013: 2 · 2012: 8
- FWCI
- 35.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Mayo Foundation for Medical Education and Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- epinephrine, glucose production, glucose clearance, beta-adrenergic receptors, alpha-adrenergic receptors, propranolol, phentolamine, adrenergic blockade, hyperglycemia, glucose infusion, insulin, glucagon, somatostatin
- MeSH terms
- Adult, Blood Glucose, Epinephrine, Glucagon, Humans, Hyperglycemia, Insulin, Male, Phentolamine, Propranolol, Receptors, Adrenergic, Receptors, Adrenergic, beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.